Phytoalexins (elicited antimicrobial plant defenses) that are resistant to pathogen degradation provide the producing plants with higher disease resistance levels, and, conversely, their transformation by pathogens makes plants more susceptible to diseases. In this context, the transformation of cruciferous phytoalexins carried out by fungal pathogens is of great concern due to the global significance of cruciferous crops. This review covers the detoxification pathways of cruciferous phytoalexins, the corresponding detoxifying enzymes and their natural and synthetic inhibitors. Paldoxins (inhibitors of fungal detoxifying enzymes) are examined as a potentially sustainable strategy to control plant pathogenic fungi. As a spin-off of the reviewed work, some of the biotransformation reactions could be applied to selectively convert more complex molecules to novel or known products.
Introduction
Pathogens and plants have co-evolved for centuries in an arms race that continues to escalate.
1,2 While plants can recognize pathogen signals and prevent invasion using various defense mechanisms, in certain circumstances pathogens are able to evade these mechanisms. Plant defense mechanisms involve numerous biosynthetic pathways that produce a great diversity of secondary metabolites (natural products) with specic roles.
Some plant defense mechanisms are constitutive and others are induced, i.e. expressed as a response to challenges posed by pathogens, pests, or environmental factors. Induced mechanisms provide the plant with an enhanced level of resistance against a range of invaders such as fungal pathogens.
3 Phytoalexins are antimicrobial plant metabolites part of the elicited defense responses caused by biotic and abiotic stress, thus are not synthesized by constitutive metabolic pathways. 4 The chemical structures of phytoalexins have diverse biosynthetic origins, and are usually related within the same plant family. For example, the majority of the cruciferous phytoalexins reported to date are derived from (S)-tryptophan, 4-7 but a new structural group derived from (S)-phenylalanine has been Between 1986, when the rst cruciferous phytoalexins were reported, and 2011, the chemical structures, syntheses and antimicrobial activities of 44 cruciferous phytoalexins were reported. 4 Since the last comprehensive review of cruciferous phytoalexins was published in 2011 ( Fig. 1) , 4 ten new phytoalexins have been reported: cyclonasturlexin (45) , 5 isocyalexin A (46) , 10 tenualexin (47), 7 nasturlexins 48-51, 53, 54 (ref. 8 and 9) and tridentatol C (52) 8 (Fig. 2) . Isocyalexin A (46) was the rst isocyanide (or isonitrile, -NC) reported from the plant kingdom, although cyanide (or nitriles, -CN) containing metabolites are common in plants. For example, tenualexin (47) , isolated from wall rocket, 7 appears to be the most potent antifungal compound among the nitrile containing phytoalexins (indolyl-3-acetonitrile (38) , caulilexin C (39) and arvelexin (40) ).
11 Interestingly, watercress is the only crucifer species reported that biosynthesizes phytoalexins using two independent pathways, initiated from the primary precursors amino acids (S)-tryptophan and (S)-phenylalanine. To date, only (S)-phenylalanine derived phytoalexins, the nasturlexins 48-51, 53, 54 and tridentatol C (52) , but no indolyl phytoalexins, were reported from winter cress and upland cress. Nitrile containing phytoalexins such as tenualexin (47) are likely biosynthesized from the corresponding indolyl acetaldoximes, while cyclonasturlexin (45) is biosynthetically derived from brassinin (1) via the indolyl glucosinolate glucobrassicin. 5 Considering the large number of crucifer species (more than 3700 species) and the relatively low number of species (<50) analyzed for phytoalexin production, it is likely that phytoalexin structures deriving from phenylalanine/ tyrosine and their homologues will match the variety of functional groups present in those derived from (S)-tryptophan.
Phytoalexins resistant to pathogen detoxycation provide the producing plants with higher disease resistance levels, and, conversely, their transformations by pathogens make plants more susceptible to diseases. Our group has pioneered work on the transformation of crucifer phytoalexins by plant pathogens and is one of the very few working in the eld. We have been investigating the metabolic transformations of various crucifer phytoalexins by fungal plant pathogens since 1991 (ref. 12 ) with the goal of developing inhibitors of these reactions as crop protection agents. An overview of the catabolic pathways of phytoalexins, their products, enzymes and inhibitors is reported.
Biotransformation and detoxification of phytoalexins
Plant fungal pathogens are able to elude plant defense mechanisms using a variety of strategies that include production of enzymes with diverse catalytic activities. 13 For example, some fungi carry out effective detoxication of metabolites such as phytoalexins using detoxifying enzymes that exhaust these valuable defenses (Fig. 3) . 14 4 The type of reaction carried out (e.g. oxidation, reduction, hydrolysis) depends on both the fungal species and the chemical structure of the phytoalexin.
Brassinin and cyclobrassinin
Brassinin (1), 1-methoxybrassinin (3) and cyclobrassinin (12) , the rst cruciferous phytoalexins reported, 15 are produced mainly by Brassica species. 27 were isolated from wild type fungal isolates, puried to homogeneity and characterized. BOLm was the rst phytoalexin detoxifying enzyme puried and characterized, a milestone achievement. The gene for brassinin glucosyl transferase (BGTSs) from S. sclerotiorum was cloned and expressed in Saccharomyces cerevisiae. The puried recombinant enzyme was able to glucosylate brassinin effectively. 28 BOLm, BHLm and BHAb are elicited detoxifying enzymes, induced by stress, not produced under normal culture conditions. Importantly, it was established that BHAb and BHLm have different physical properties and substrate specicities, although both enzymes catalyze the hydrolysis of brassinin (1) to the corresponding amine (57). 26 More recently, cyclobrassinin hydrolase was isolated from A. brassicicola (CHAb), puried to homogeneity and shown to have different substrate specicity and characteristics from those of BHAb.
29
Unexpectedly, it was discovered that the cruciferous phytoalexins cyclobrassinin (12) , camalexin (35) and wasalexins A (8) and B (9), inhibited BOLm activity, 27 whereas cyclobrassinin (12) inhibited BHAb and BHLm, 26 and camalexin (35) , dioxibrassinin (22) and brassilexin (20) inhibited CHAb (Table 1) . 29 These discoveries suggest that phytoalexin blends produced in crucifers have multiple functions, including inhibition of specic fungal detoxifying enzymes, in addition to the role of inhibiting the growth of microbial pathogens.
The design of selective inhibitors (coined paldoxins, phytoalexin detoxication inhibitors) of these fungal detoxifying enzymes was proposed as a strategy to protect crops that produce the corresponding phytoalexins. 30 Selective inhibitors of such detoxifying enzymes, i.e. paldoxins, are less likely to affect non-targeted organisms, thus are anticipated to have lower impact on ecosystems and become a sustainable strategy to control plant pathogens. Paldoxins could prevent the depletion of the plants' natural defenses by the detoxifying enzymes of plant pathogens. By denition, the ideal paldoxins would not be toxic to living organisms, whether animal, plant or microbe.
31
Initially, potential paldoxins of BOLm were designed by replacement of the dithiocarbamate group of brassinin (1) with various functional groups and of the indolyl moiety with naphthalenyl and phenyl moieties. 32 In vitro screening of this synthetic library using puried BOLm indicated that none of the synthetic compounds were inhibitory to BOLm, but demonstrated for the rst time that the phytoalexins camalexin (35) and cyclobrassinin (12) were competitive inhibitors of BOLm. 27 Later on, compounds with scaffolds based on various phytoalexins (Table 1) , including camalexin (35) 33 and brassilexin (20) , 34 were shown to inhibit BOLm. 6-Chlorobrassilexin (74) and 5-methoxycamalexin (66) were determined to be the best competitive inhibitors of BOLm to date (Table 1) . 34 However, due to their substantial antifungal activity against L. maculans, these inhibitors are not considered paldoxins. This antifungal activity is not surprising considering that the designed inhibitor structures were based on phytoalexins. More recently, synthetic compounds that did not contain the indole nucleus and displayed low antifungal activity were found to inhibit BHAb, 35 suggesting that such potential paldoxins could be applied to protect mustard crops against A. brassicicola.
Wasalexins A and B
Wasalexins A (8) and B (9) were isolated from the crucifers wasabi 36 and salt cress, 37 whereas only wasalexin A (8) was isolated from stinkweed. 38 Wasalexins A (8) and B (9) were obtained by synthesis as a mixture of E (8) and Z (9) isomers in a 2 : 1 ratio. 39 Although the more stable E isomer (8) could be separated by crystallization of the synthetic mixture, 9 could not be obtained as a single compound. For this reason, metabolic studies were conducted with 8 as a single compound, but investigation of the metabolism of 9 was conducted using a mixture of 8 and 9 (2 : 1 ratio). 40 It was determined that wasalexin A (8) detoxied by both canola and brown mustard virulent isolates of L. maculans via reduction of the double bond in the side chain of the oxoindole ring, as summarized in Scheme 3.
40 Because both wasalexins A (8) and B (9) were detoxied by L. maculans canola and brown mustard isolates, a correlation between the production of wasalexins by the three plant species (all reported to be resistant to L. maculans canola virulent isolates) and their disease resistance to L. maculans could not be established. It is conceivable that in planta, additional metabolites are produced that inhibit the metabolism of wasalexins by L. maculans.
Brassilexin and sinalexin
L. maculans canola virulent isolates detoxied brassilexin (20) , via 3-aminomethyleneindole-2-thione (65), to the polar metabolite 3-formylindolyl-2-sulfonic acid (90, Scheme 4). 41 Similar to brassilexin (20) , sinalexin (21) was detoxied by reduction of the isothiazole ring to 3-aminomethylene-1-methoxyindole-2-thione (92), which decomposed spontaneously in aqueous solution.
41 Similar to brassinins 1 and 3 and cyclobrassinin (12), S. sclerotiorum detoxied both brassilexin (20) and sinalexin (21) to the glucosyl derivatives 91 and 94, respectively. 
Rutalexin, isalexin and rapalexin A
The pathway for transformation of rutalexin (19) , a rutabaga phytoalexin, by A. brassicicola has been reported recently to produce the hybrid metabolite rutapyrone (Scheme 5). 43 In cultures of A. brassicicola rutalexin (19) was hydrolyzed and decarboxylated to the sulfanylamide 95, which in turn reacted with the least hindered epoxide carbon of phomapyrone G (98) to yield the adduct rutapyrone (96). Sulfanylamide 95 oxidized spontaneously to the disulde 97 (the major product), which in solution oxidized spontaneously to several other products. 43 The biotransformation of isalexin (44) , another rutabaga phytoalexin, in cultures of A. brassicicola yielded several products that included 1,3-dihydro-3-hydroxy-4-methoxyindol-2-one (99).
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This structure was conrmed by comparison with a synthetic sample prepared by NaBH 4 reduction of isalexin (44) . In solution, metabolite 99 re-oxidized spontaneously to isalexin (44) . By contrast, rapalexin A (42), a rutabaga phytoalexin as well, was stable in cultures of A. brassicicola.
Brassicanal A and brassicanate A
Brassicanal A (28) was hydroxylated by R. solani 25 to 63, and transformed by L. maculans (canola virulent isolates) 44 and S. sclerotiorum 42 to brassicanal A sulfoxide (100) and 3-hydroxymethylindole-2-methylsulfoxide (101); 101 was further transformed by L. maculans to 3-methylindole-2-methylsulfoxide (102), as shown in Scheme 6. The biotransformation products were signicantly less inhibitory to R. solani, L. maculans and S. sclerotiorum, hence these transformations were considered detoxications. The transformation of brassicanate A (33), another rutabaga phytoalexin, by A. brassicicola yielded 2-methylsulfanediylindole-3-carboxylic acid (103), which spontaneously decarboxylated in aqueous acidic solutions to yield the non-toxic product 104 (Scheme 6). 43 
Dioxibrassinin, brussalexin A, spirobrassinins and erucalexin
Dioxibrassinin (22) was metabolized by canola virulent isolates of L. maculans, but no biotransformation products were detected or isolated, 23 whereas brown mustard virulent isolates detoxied dioxibrassinin (22) to 2 0 -thioxospiro[indoline-3,5 0 -oxazolidin]-2-one (105) (Scheme 7). 45 By contrast, brussalexin A (41) was not stable in culture medium or in water, yielding indolyl-3-methanol that decomposed to yield mainly 3,3 0 -diindolylmethane.
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Spirobrassinin (24) was not transformed by L. maculans canola virulent isolates but was transformed by brown mustard virulent isolates to metabolite 106 (Scheme 7). 45 1-Methoxyspirobrassinin (25) was metabolized to the spirothiazolidinethione 108 by L. maculans (brown mustard virulent isolates) (Scheme 7).
45 S. sclerotiorum transformed both spirobrassinin (24) and 1-methoxyspirobrassinin (25) to metabolites 107-109 (Scheme 7). 42 Because S. sclerotiorum did not use glucosylating enzymes to transform 24 and 25, it was suggested that glucosylating enzymes were only used for detoxication of phytoalexins with strong antifungal activities against this fungus.
42 Erucalexin (27) was detoxied by L. maculans (canola virulent isolates) by reduction to a diastereomeric mixture of 3-dihydroerucalexins (110) (Scheme 8). The relative congurations of the diastereomeric mixture of dihydroerucalexins were established by 1 H NMR and NOE spectroscopy. 46 
Camalexins
The phytoalexin camalexin (35) is perhaps the most studied of the cruciferous phytoalexins, not surprisingly because it is produced by a crucifer model species (A. thaliana) that had its products of transformation of camalexin (35) by each fungal species were different, except for the detoxication pathway of camalexin (35) in A. brassicicola and B. cinerea that occurred via identical intermediates (Scheme 9). In all cases the nal products were found to be less toxic to each species than camalexin (35) . The rate of transformation of camalexin (35) by A. brassicicola 48 was much slower than that observed by B. cinerea.
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Different transformation rates are consistent with the defensive role of camalexin (35) in A. thaliana, which displays resistance to A. brassicicola and susceptibility to B. cinerea. It is noteworthy that glucosylation of camalexin (35) was preceded by oxidation of C-6 (Scheme 9), whereas direct glucosylation of the indole nitrogen of the phytoalexins brassinin (1), cyclobrassinin (12) and brassilexin (20) 11 Acids 128 and 56, unlike the parent metabolite indolyl-3-acetonitrile (38), had no detectable inhibitory effects on any of the fungal species.
Conclusion and prospects
As summarized in Table 2 , the metabolism and detoxication pathways of more than twenty cruciferous phytoalexins by plant pathogenic fungal species have been reported. Because rapalexin A (42) and camalexin (35) are not metabolized by L. maculans, these phytoalexins are of great interest to improve the disease resistance of crucifers to this pathogen, one of the most destructive to oilseed crops. In addition, because camalexins 35-37 are transformed slowly by A. brassicicola, incorporation of the biosynthetic pathway of camalexins into cultivated Brassica species could have a great positive impact in obtaining resistance to both L. maculans and A. brassicicola. Incorporation of novel defense pathways in agriculturally important crops through plant breeding is an alternative that could decrease the unsustainable use of fungicides.
To date, ve fungal enzymes mediating the detoxication of brassinin (1) and cyclobrassinin (12) were puried and characterized: BOLm, BHLm, BHAb, CHAb and BGTSs. The enzymes involved in these detoxications were shown to be inducible and display substrate specicity. Remarkably, it was established that some crucifer phytoalexins are competitive inhibitors of these detoxifying enzymes. This unprecedented conclusion suggested that phytoalexin blends, e.g. brassinin (1) and cyclobrassinin (12) , produced by particular plant species in response to attack by a pathogen have multiple functions, including inhibition of fungal growth and inhibition of specic enzymes produced by pathogenic fungi to overcome the plants' defenses.
Finally, as a spin off of the work reviewed above, some of the biotransformation reactions could be applied to selectively convert complex molecules to novel or known products. For example, considering that the fungus S. sclerotiorum is easy to culture and carries out efficient and selective glucosylation of indolyl compounds containing diverse functional groups, including brassinin (1), brassilexin (20) , sinalexin (21) and camalexin (35) , this fungal species could be exploited for the selective glucosylation of more complex substrates.
Based on work carried out over more than two decades, a new strategy to control fungal pathogens of crucifers has emerged. That is, because specic crucifer fungal pathogens produce specic enzymes to detoxify cruciferous phytoalexins, it follows that selective inhibitors of these enzymes, coined paldoxins, could be designed and produced to prevent phytoalexin degradation in planta (Fig. 4) . For example, considering that the detoxications of brassinin (1) and cyclobrassinin (12) are carried out by specic enzymes (BOLm, BHLm, BHAb, CHAb), application of paldoxins of these enzymes to plants could enable the accumulation of 1 and 12 (and their derivatives) to levels necessary to inhibit pathogen growth. In addition, paldoxins of the enzymes that catalyze the detoxications of brassilexin (20) , sinalexin (21) and camalexins 35-37 could have similar application, yet these enzymes remain to be puried and characterized. Nonetheless, in examples where phytoalexins are detoxied by multiple parallel pathways, the paldoxin strategy is unlikely to have a positive impact in controlling plant fungal pathogens.
It has been proposed that the ideal paldoxins need to be selective inhibitors that could allow accumulation of a plant's own defenses. Selective inhibitors are less likely to affect nontargeted organisms and thus are anticipated to have lower impact on cultivated ecosystems. As such, paldoxins cannot be toxic to living organisms, whether animal, plant or microbe. Furthermore, mixtures of paldoxins to act synergistically with the natural disease resistance factors of plants could be optimized to effectively protect crops with minimal environmental impact. In conclusion, further work needs to be done to advance the current knowledge on phytoalexin detoxication and design of inhibitors before eld applications of this strategy can be adopted. 
